Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus Clinical Trials
3 recruiting trials for Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Sara A Belal (1), Hywel Dda Health Board (1), IRCCS Ospedale San Raffaele (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood draw for the laboratory assessment (other, 1 trial), followed by Urine sample, Ophthalmological examination including imaging assessments.
Track Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy
This study aims to test the impact of new-generation anti-diabetic drugs, such as SGLT2 inhibitors and DPP-4 inhibitors, on the development of diabetic retinopathy (DR). The study...
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and...
Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye...
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
Despite the evidence that diabetic retinopathy (DR) remains the first cause of blindness among the working-age population, it lacks a specific preventive treatment. This is...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.